Marshall Wace’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.71M | Buy |
2,376,304
+1,113,937
| +88% | +$1.62M | ﹤0.01% | 1451 |
|
|
2025
Q4 | $1.45M | Buy |
+1,262,367
| New | +$1.73M | ﹤0.01% | 1752 |
|
|
2024
Q4 | – | Sell |
-574,150
| Closed | -$901K | – | 2847 |
|
|
2024
Q3 | $901K | Sell |
574,150
-616,298
| -52% | -$1.1M | ﹤0.01% | 1689 |
|
|
2024
Q2 | $2M | Buy |
1,190,448
+691,276
| +138% | +$1.24M | ﹤0.01% | 1369 |
|
|
2024
Q1 | $1.2M | Buy |
+499,172
| New | +$1.07M | ﹤0.01% | 1581 |
|
|
2023
Q3 | – | Sell |
-125,287
| Closed | -$287K | – | 2519 |
|
|
2023
Q2 | $287K | Buy |
+125,287
| New | +$333K | ﹤0.01% | 2155 |
|
|
2020
Q4 | – | Sell |
-281,647
| Closed | -$406K | – | 2065 |
|
|
2020
Q3 | $406K | Sell |
281,647
-654,944
| -70% | -$1.17M | ﹤0.01% | 1288 |
|
|
2020
Q2 | $1.87M | Sell |
936,591
-409,019
| -30% | -$801K | 0.01% | 816 |
|
|
2020
Q1 | $2.62M | Buy |
1,345,610
+494,682
| +58% | +$1.47M | 0.03% | 540 |
|
|
2019
Q4 | $3.53M | Buy |
+850,928
| New | +$3.28M | 0.03% | 646 |
|
|
2019
Q1 | – | Sell |
-264,139
| Closed | -$1.75M | – | 1918 |
|
|
2018
Q4 | $1.75M | Buy |
264,139
+229,876
| +671% | +$1.86M | 0.02% | 763 |
|
|
2018
Q3 | $366K | Sell |
34,263
-616,555
| -95% | -$7.06M | ﹤0.01% | 990 |
|
|
2018
Q2 | $7.81M | Sell |
650,818
-85,727
| -12% | -$877K | 0.12% | 211 |
|
|
2018
Q1 | $6.31M | Buy |
+736,545
| New | +$6.81M | 0.26% | 92 |
|
|
2015
Q3 | – | Sell |
-12,945
| Closed | -$104K | – | 1007 |
|
|
2015
Q2 | $104K | Sell |
12,945
-63,724
| -83% | -$468K | ﹤0.01% | 855 |
|
|
2015
Q1 | $507K | Buy |
+76,669
| New | +$524K | 0.01% | 668 |
|
Other funds holding LXRX
AG
SL
SC
VCM
